Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk

The known genetic risk factors for malignant melanoma, besides CDKN2A and CDK4 mutations, include variant alleles of the melanocortin-1 receptor (MC1R) gene ( 1 ) . Recently, Soufir et al. ( 2 ) in a study that was based on 137 malignant melanoma patients and 131 ethnically matched control subje...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Thirumaran, Ranjit Kumar (VerfasserIn) , Figl, Adina (VerfasserIn) , Ugurel, Selma (VerfasserIn) , Hemminki, Kari (VerfasserIn) , Schadendorf, Dirk (VerfasserIn) , Kumar, Rajiv (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 06 September 2006
In: Journal of the National Cancer Institute
Year: 2006, Jahrgang: 98, Heft: 17, Pages: 1252-1253
ISSN:1460-2105
DOI:10.1093/jnci/djj336
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jnci/djj336
Volltext
Verfasserangaben:Ranjit K. Thirumaran, Adina Thoelke, Selma Ugurel, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar

MARC

LEADER 00000caa a2200000 c 4500
001 1747635618
003 DE-627
005 20230426111207.0
007 cr uuu---uuuuu
008 210205s2006 xx |||||o 00| ||eng c
024 7 |a 10.1093/jnci/djj336  |2 doi 
035 |a (DE-627)1747635618 
035 |a (DE-599)KXP1747635618 
035 |a (OCoLC)1341391735 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Thirumaran, Ranjit Kumar  |d 1978-  |e VerfasserIn  |0 (DE-588)132214466  |0 (DE-627)519239571  |0 (DE-576)299010074  |4 aut 
245 1 0 |a Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk  |c Ranjit K. Thirumaran, Adina Thoelke, Selma Ugurel, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar 
264 1 |c 06 September 2006 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.02.2021 
520 |a The known genetic risk factors for malignant melanoma, besides CDKN2A and CDK4 mutations, include variant alleles of the melanocortin-1 receptor (MC1R) gene ( 1 ) . Recently, Soufir et al. ( 2 ) in a study that was based on 137 malignant melanoma patients and 131 ethnically matched control subjects reported an association between nonsynonymous variants in the endothelin receptor B (EDNRB) gene and increased risk of melanoma. They reported six nonsynonymous EDNRB variants in 15 patients compared with two variants in four control subjects. EDNRB promotes migration and proliferation of melanocyte precursors during embryonic development ( 3 ) . The overexpression of EDNRB in most human melanomas and the shrinkage of tumors in immunocompromised mice and induction of apoptosis upon inhibition of EDNRB suggest a role in disease progression ( 4 , 5 ) . Mutations in the gene are associated with several genetic disorders. The most common variant detected by Soufir et al. in 12 melanoma patients and three control subjects, S305N, has previously been reported in Hirschsprung disease ( 2 , 6 ) . 
700 1 |a Figl, Adina  |d 1975-  |e VerfasserIn  |0 (DE-588)1146398816  |0 (DE-627)1005834245  |0 (DE-576)186024819  |4 aut 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
700 1 |a Hemminki, Kari  |d 1947-  |e VerfasserIn  |0 (DE-588)1150735872  |0 (DE-627)1010964402  |0 (DE-576)172043751  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
700 1 |a Kumar, Rajiv  |d 1955-  |e VerfasserIn  |0 (DE-588)1164253425  |0 (DE-627)1028811942  |0 (DE-576)508469805  |4 aut 
773 0 8 |i Enthalten in  |a National Cancer Institute  |t Journal of the National Cancer Institute  |d Oxford : Oxford Univ. Press, 1941  |g 98(2006), 17, Seite 1252-1253  |w (DE-627)265780713  |w (DE-600)1465951-7  |w (DE-576)074959581  |x 1460-2105  |7 nnas 
773 1 8 |g volume:98  |g year:2006  |g number:17  |g pages:1252-1253  |g extent:2  |a Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk 
856 4 0 |u https://doi.org/10.1093/jnci/djj336  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210205 
993 |a Article 
994 |a 2006 
998 |g 1164253425  |a Kumar, Rajiv  |m 1164253425:Kumar, Rajiv  |p 6  |y j 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 5 
998 |g 1150735872  |a Hemminki, Kari  |m 1150735872:Hemminki, Kari  |d 50000  |e 50000PH1150735872  |k 0/50000/  |p 4 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 60000  |e 60000PU122030923  |k 0/60000/  |p 3 
998 |g 1146398816  |a Figl, Adina  |m 1146398816:Figl, Adina  |d 140000  |e 140000PF1146398816  |k 0/140000/  |p 2 
999 |a KXP-PPN1747635618  |e 3849400859 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ranjit K. Thirumaran, Adina Thoelke, Selma Ugurel, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar"]},"recId":"1747635618","note":["Gesehen am 05.02.2021"],"physDesc":[{"extent":"2 S."}],"person":[{"given":"Ranjit Kumar","family":"Thirumaran","display":"Thirumaran, Ranjit Kumar","role":"aut"},{"role":"aut","given":"Adina","family":"Figl","display":"Figl, Adina"},{"role":"aut","given":"Selma","display":"Ugurel, Selma","family":"Ugurel"},{"display":"Hemminki, Kari","family":"Hemminki","given":"Kari","role":"aut"},{"family":"Schadendorf","display":"Schadendorf, Dirk","given":"Dirk","role":"aut"},{"family":"Kumar","display":"Kumar, Rajiv","given":"Rajiv","role":"aut"}],"title":[{"title_sort":"Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk","title":"Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk"}],"relHost":[{"part":{"issue":"17","extent":"2","year":"2006","text":"98(2006), 17, Seite 1252-1253","pages":"1252-1253","volume":"98"},"title":[{"title_sort":"Journal of the National Cancer Institute","subtitle":"JNCI","title":"Journal of the National Cancer Institute"}],"titleAlt":[{"title":"Journal of the National Cancer Institute online"},{"title":"JNCI"}],"origin":[{"dateIssuedKey":"1941","publisher":"Oxford Univ. Press","publisherPlace":"Oxford","dateIssuedDisp":"1941-"}],"corporate":[{"display":"National Cancer Institute","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"id":{"zdb":["1465951-7"],"issn":["1460-2105"],"eki":["265780713"]},"pubHistory":["1.1940/41(1941) -"],"recId":"265780713","note":["Gesehen am 18.02.14"],"disp":"National Cancer InstituteJournal of the National Cancer Institute"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1093/jnci/djj336"],"eki":["1747635618"]},"language":["eng"],"origin":[{"dateIssuedDisp":"06 September 2006","dateIssuedKey":"2006"}]} 
SRT |a THIRUMARANREASSOCIAT0620